Helios: Achieve Targeted Fat Loss and Improved Body Composition with Dragon Pharmaceuticals

Helios by Dragon Pharma combines Clenbuterol (40 mcg/ml) and Yohimbine (5.4 mg/ml) in a 10 ml injectable vial, delivering a powerful synergistic formula for fat loss and energy enhancement. This blend targets stubborn fat, boosts metabolism, and increases workout intensity, making it a top choice for bodybuilders and athletes in cutting cycles aiming for a shredded, vascular physique. With Clenbuterol's half-life of ~36 hours and Yohimbine's ~2–6 hours, Helios provides sustained fat-burning effects.

What It Is

Helios is a unique injectable blend of Clenbuterol, a beta-2 agonist, and Yohimbine, an alpha-2 adrenergic antagonist. Clenbuterol stimulates thermogenesis and fat oxidation, while Yohimbine enhances lipolysis by blocking fat-storing receptors, particularly in stubborn areas like the abdomen and thighs. Originally developed for medical use (Clenbuterol for asthma, Yohimbine for erectile dysfunction), Helios is widely used in bodybuilding for its potent fat-burning and performance-enhancing properties.

How It Works

Clenbuterol activates beta-2 adrenergic receptors, increasing metabolic rate, thermogenesis, and fat oxidation while preserving lean muscle. Yohimbine inhibits alpha-2 receptors, promoting the release of stored fat for energy, especially in hard-to-lose areas. The injectable delivery ensures rapid absorption and localized fat loss, amplifying the synergistic effects of both compounds. This combination boosts energy, enhances workout performance, and supports a leaner physique without significant muscle loss.

Benefits

• Accelerated Fat Loss: Targets stubborn fat through thermogenesis and lipolysis.
• Enhanced Energy: Boosts stamina and workout intensity.
• Muscle Preservation: Maintains lean muscle during cutting cycles.
• Localized Fat Reduction: Injectable delivery targets specific fat deposits.
• Improved Performance: Increases endurance and focus for training.

Who It's For

Helios is ideal for male and female bodybuilders and athletes aged 21–40 in cutting cycles, seeking rapid fat loss, energy enhancement, and a defined physique. It's suitable for intermediate to advanced users familiar with fat-burning compounds. Not for: Individuals under 21, those with cardiovascular conditions (e.g., hypertension, arrhythmias), or those sensitive to stimulants. Medical supervision and blood work are essential.

How to Use

Dosage: Typical dosage is 0.25–1 ml/day (equivalent to 10–40 mcg Clenbuterol and 1.35–5.4 mg Yohimbine), injected subcutaneously. Beginners should start at 0.25 ml/day to assess tolerance, increasing gradually to 0.5–1 ml/day. Women may use lower doses (0.25–0.5 ml/day).

Administration: Inject subcutaneously into fatty areas (e.g., abdomen, thighs) using a 0.5-inch insulin syringe (27–30G). Administer in the morning to align with circadian rhythms and avoid sleep disruption. Cycles typically last 2–4 weeks, followed by a 2–4 week break to prevent receptor downregulation.

Results Timeline: Fat loss and energy increases are noticeable within 3–7 days, with significant body composition changes by 2–4 weeks when paired with a calorie-deficit diet and cardio.

Stacking Suggestions

Helios is ideal for cutting stacks:

• Cutting Stack: Combine with Anavar (10–20 mg/day) or Winstrol (25–50 mg/day) for enhanced fat loss and muscle definition.
• Endurance Stack: Pair with Cardarine (10–20 mg/day) for synergistic fat-burning and stamina benefits.
• Support: Use with Taurine (3–5 g/day) to reduce Clenbuterol-induced cramps and Milk Thistle for liver support.

Side Effects

Helios may cause side effects due to its stimulant properties:

• Cardiovascular: Increased heart rate, palpitations, or elevated blood pressure.
• Neurological: Jitters, anxiety, or insomnia, especially at higher doses.
• Muscular: Tremors or cramps due to Clenbuterol; supplement with taurine.
• Hepatotoxicity: Minimal, but monitor liver function with prolonged use.

Regular monitoring of blood pressure, heart rate, and liver function is recommended. Avoid if sensitive to stimulants.

Post Cycle Therapy (PCT)

Helios does not suppress testosterone, so PCT is not required unless stacked with anabolic steroids. If stacked with testosterone or other suppressive compounds, use Clomid (50 mg/day) and Nolvadex (20–40 mg/day) for 4–6 weeks post-cycle. Take a 2–4 week break between Helios cycles to maintain efficacy.

Warnings / Disclaimer

Helios is intended for research purposes only unless prescribed by a licensed physician. It is not suitable for individuals under 21, those with cardiovascular or thyroid conditions, or those sensitive to stimulants. Regular monitoring of blood pressure, heart rate, and liver function is essential. Store at room temperature, away from moisture and children.